首页> 外文期刊>Chemical biology and drug design >Synthesis of Novel Nalidixic Acid-Based 1,3,4-Thiadiazole and 1,3,4-Oxadiazole Derivatives as Potent Antibacterial Agents
【24h】

Synthesis of Novel Nalidixic Acid-Based 1,3,4-Thiadiazole and 1,3,4-Oxadiazole Derivatives as Potent Antibacterial Agents

机译:新型萘啶酸为基础的1,3,4-噻二唑和1,3,4-恶二唑衍生物作为强效抗菌剂的合成

获取原文
获取原文并翻译 | 示例
           

摘要

Novel nalidixic acid-based 1,3,4-thia(oxa)diazoles, their thio ethers, sulfones, bis mercapto, and Mannich bases were synthesized and characterized by Infrared spectra, ~1H NMR, ~(13)C NMR, and elemental analysis. These compounds were evaluated for their antibacterial activity against two Gram-positive and three Gram-negative bacteria. The preliminary bioassay showed that most of the compounds had better antibacterial activity than the parent compounds, 1,3,4-thia(oxa)diazoles, at the dosage 50 μg ?mL toward five test bacteria. Four Mannich bases of nalidixic acid-based 1,3, 4-thiadiazole exhibited maximum antibacterial activity against Bacillus subtilis, Klebsiella pneumoniae, and Pseudomonas aeruginosa with minimum inhibitory concentration in the range of 6.25–125 μg ?mL.
机译:合成了基于萘啶酸的新型1,3,4-硫杂二恶唑,其硫醚,砜,双巯基和曼尼希碱,并通过红外光谱,〜1H NMR,〜(13)C NMR和元素进行了表征分析。评估了这些化合物对两种革兰氏阳性和三种革兰氏阴性细菌的抗菌活性。初步的生物测定结果表明,大多数化合物对五个试验细菌的剂量为50μg?mL时,其母体化合物1,3,4-硫杂二氧杂唑的抗菌活性均优于母体化合物。以萘啶酸为基础的1,3,4-噻二唑的四个曼尼希碱对枯草芽孢杆菌,肺炎克雷伯菌和铜绿假单胞菌具有最大的抑菌活性,其最小抑菌浓度在6.25–125μg?mL之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号